Isabelle Bardoulat

567 total citations
26 papers, 395 citations indexed

About

Isabelle Bardoulat is a scholar working on Epidemiology, General Health Professions and Surgery. According to data from OpenAlex, Isabelle Bardoulat has authored 26 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in General Health Professions and 3 papers in Surgery. Recurrent topics in Isabelle Bardoulat's work include Healthcare Systems and Practices (4 papers), Neurological Complications and Syndromes (2 papers) and Renal Transplantation Outcomes and Treatments (2 papers). Isabelle Bardoulat is often cited by papers focused on Healthcare Systems and Practices (4 papers), Neurological Complications and Syndromes (2 papers) and Renal Transplantation Outcomes and Treatments (2 papers). Isabelle Bardoulat collaborates with scholars based in France, United States and Greece. Isabelle Bardoulat's co-authors include Frédérique Maurel, C. Paul, Ortonne Jp, B Amor, C. Le Pen, Nathalie Pelletier‐Fleury, Nicolás Meyer, Laurence Watier, Anaïs Chosidow and Steven Duret and has published in prestigious journals such as PLoS ONE, Annals of the Rheumatic Diseases and Allergy.

In The Last Decade

Isabelle Bardoulat

21 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabelle Bardoulat France 10 103 74 72 62 55 26 395
Santiago Jiménez Spain 15 164 1.6× 107 1.4× 35 0.5× 44 0.7× 160 2.9× 42 624
Berta Juliá Spain 13 129 1.3× 69 0.9× 39 0.5× 43 0.7× 81 1.5× 45 505
K Kaulback United States 13 111 1.1× 14 0.2× 143 2.0× 17 0.3× 134 2.4× 23 519
Maria C. Harpsøe Denmark 8 137 1.3× 113 1.5× 20 0.3× 50 0.8× 121 2.2× 9 524
Ewa Toporowska‐Kowalska Poland 14 130 1.3× 158 2.1× 9 0.1× 12 0.2× 156 2.8× 51 541
Remziye Tanaç Türkiye 13 60 0.6× 33 0.4× 56 0.8× 17 0.3× 77 1.4× 46 498
Shunichiro Nakao Japan 11 48 0.5× 41 0.6× 12 0.2× 10 0.2× 82 1.5× 64 359
Maria De Filippo Italy 15 33 0.3× 71 1.0× 55 0.8× 124 2.0× 157 2.9× 64 628
Lauren N. Ko United States 11 57 0.6× 7 0.1× 65 0.9× 29 0.5× 67 1.2× 32 392
Mark Forshag United States 12 51 0.5× 67 0.9× 17 0.2× 35 0.6× 125 2.3× 16 604

Countries citing papers authored by Isabelle Bardoulat

Since Specialization
Citations

This map shows the geographic impact of Isabelle Bardoulat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Bardoulat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Bardoulat more than expected).

Fields of papers citing papers by Isabelle Bardoulat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Bardoulat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Bardoulat. The network helps show where Isabelle Bardoulat may publish in the future.

Co-authorship network of co-authors of Isabelle Bardoulat

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Bardoulat. A scholar is included among the top collaborators of Isabelle Bardoulat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Bardoulat. Isabelle Bardoulat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anglicheau, Dany, Antoine Dürrbach, Isabelle Bardoulat, et al.. (2025). Immunosuppressive treatment patterns in kidney transplant recipients in France: an insurance claims database study (OISTER) over a 12 year period. Journal of Nephrology. 38(4). 1229–1237.
2.
Steichen, Olivier, Isabelle Bardoulat, Delphine Viriot, et al.. (2025). High incidence of pneumonia cases observed in children seen in general practice consultations during the 2023–2024 season, France. PubMed. 17(1). 6–6.
4.
Chan‐Chee, Christine, Nicolas Coulombel, Isabelle Bardoulat, et al.. (2022). Trends and characteristics of attempted and completed suicides reported to general practitioners before vs during the COVID-19 pandemic in France: Data from a nationwide monitoring system, 2010–2022. PLoS ONE. 17(12). e0278266–e0278266. 1 indexed citations
5.
Souty, Cécile, Clément Turbelin, Thierry Blanchon, et al.. (2021). Common communicable diseases in the general population in France during the COVID-19 pandemic. PLoS ONE. 16(10). e0258391–e0258391. 23 indexed citations
6.
Demont, Clarisse, Isabelle Bardoulat, Steven Duret, et al.. (2021). Economic and disease burden of RSV-associated hospitalizations in young children in France, from 2010 through 2018. BMC Infectious Diseases. 21(1). 730–730. 62 indexed citations
7.
Toussi, Massoud, et al.. (2020). Effectiveness of risk minimisation measures for valproate: A cross‐sectional survey among physicians in Europe. Pharmacoepidemiology and Drug Safety. 30(3). 283–291. 4 indexed citations
9.
10.
Toussi, Massoud, Isabelle Bardoulat, Hasan S. Jafri, Judith Falloon, & Kellie Ryan. (2017). Healthcare Resource Utilization and Cost Related to Nosocomial Pneumonia Caused by Staphylococcus aureus and Pseudomonas aeruginosa in France: A 2010-2011 Population-Based Cohort Study Using a National Claims Database. Epidemiology Open Access. 7(4). 2 indexed citations
11.
Bardoulat, Isabelle, et al.. (2017). L’observance médicamenteuse des patients diabétiques de type II en Île-de-France : état des lieux et priorités d’actions. Revue d Épidémiologie et de Santé Publique. 65. S137–S137. 2 indexed citations
13.
Lefrant, Jean‐Yves, B. Garrigues, C. Pribil, et al.. (2015). The daily cost of ICU patients: A micro-costing study in 23 French Intensive Care Units. Anaesthesia Critical Care & Pain Medicine. 34(3). 151–157. 38 indexed citations
14.
Maurel, Frédérique, et al.. (2015). Quality of Life in Patients Suffering from Active Exudative Age-Related Macular Degeneration: The EQUADE Study. Ophthalmologica. 234(3). 151–159. 29 indexed citations
15.
Calvez, Thierry, Hérvè Chambost, Chantal Rothschild, et al.. (2015). EQOFIX: a combined economic and quality‐of‐life study of hemophilia B treatments in France. Transfusion. 55(7). 1787–1797. 13 indexed citations
16.
Benjamin, L., et al.. (2014). Patterns of use of oral anticancer treatments in France: a Retrospective Analysis of Cancer Treatments given ORally from 2004 to 2012 (Re-ACTOR study). Current Medical Research and Opinion. 31(2). 323–332. 8 indexed citations
17.
Varannes, Stanislas Bruley des, et al.. (2012). Gastroesophageal reflux disease: Impact on work productivity and daily-life activities of daytime workers. A French cross-sectional study. Digestive and Liver Disease. 45(3). 200–206. 10 indexed citations
18.
Garrigues, B., et al.. (2011). PHP75 The Cost Per Day of Intensive Care Units (ICU) in France: The CRRÉA Study. Value in Health. 14(7). A346–A347. 1 indexed citations
19.
Meyer, Nicolás, et al.. (2010). Psoriasis: an epidemiological evaluation of disease burden in 590 patients. Journal of the European Academy of Dermatology and Venereology. 24(9). 1075–1082. 90 indexed citations
20.
Meyer, Nicole, et al.. (2009). PSS39 PSORIASIS: AN EPIDEMIOLOGIC EVALUATION OF DISEASE BURDEN IN 590 PATIENTS. Value in Health. 12(7). A459–A460.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026